JYOTHYLABNSEJyothy Labs Limited· Personal CareHighNeutral
Announced Mon, 4 May · 15:14 IST

Jyothy Labs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 14, 2026

Exceptional ItemResults View source PDF

JYOTHYLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.2%1-day move
₹266.01
prior close
₹271.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.6-1.5-2.3+0.2-3.0-2.3-1.9-11.2-16.5-23.2-24.8-28.4
Up moveDown movePending
AI summary

Jyothy Labs Limited reported audited FY2026 results with revenue from operations of Rs. 2,94,429 lakhs, up 3.5% from Rs. 2,84,392 lakhs in FY2025. However, profit after tax declined 10.2% to Rs. 33,319 lakhs from Rs. 37,117 lakhs in the prior year. EPS for FY2026 stood at Rs. 9.07 versus Rs. 10.11 in FY2025. The Board recommended a final dividend of Rs. 3.50 per equity share (face value Rs. 1), subject to shareholder approval at the 35th AGM scheduled for July 14, 2026. The statutory auditors, B S R & Co. LLP, issued an unmodified (clean) opinion on the financial statements. An exceptional item of Rs. 370 lakhs (loss on sale of subsidiary) was recognized in the prior year comparative period. The Household Insecticides segment continues to report losses at Rs. 464 lakhs for FY2026.

Likely market impact

The 10% decline in PAT despite modest revenue growth indicates margin compression, which could concern investors. However, the clean audit opinion and dividend declaration provide some comfort. The stock may see mixed reaction given the profitability decline versus steady revenue.